Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Phase 4: AOD 9604 cycle break (week 17+) After 12-16 weeks of AOD 9604, discontinue it for a 4-week break while continuing tirzepatide
You should not use NAD+ if you have a known allergy to NAD+ or any ingredient in the injection
Safety Considerations Reconstitution and handling of semaglutide must always follow the sterile technique
They are not to be used for personal ingestion, medical treatment, or any application outside properly authorized laboratory research.
This therapy can be beneficial for a wide variety of foot conditions and foot pain, as well as wound care, inflammation, tendinitis, scar tissue, cartilage damage, and much more
While generally safe, certain individuals should avoid AOD-9604, including: Pregnant or breastfeeding women Due to limited safety data
